NCT03678883 2026-04-039-ING-41 in Patients With Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT02495896 2025-11-10Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid TumorsUniversity of Southern CaliforniaPhase 1 Active not recruiting61 enrolled
NCT04068896 2025-05-29Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination TherapyNGM Biopharmaceuticals, IncPhase 1/2 Completed89 enrolled 21 charts
NCT04336098 2024-06-04Study of SRF617 in Patients With Advanced Solid TumorsCoherus Oncology, Inc.Phase 1 Completed85 enrolled
NCT02309177 2019-05-31Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast CancerCelgenePhase 1 Completed114 enrolled
NCT02331251 2018-07-02Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)Western Regional Medical CenterPhase 1/2 Terminated81 enrolled